NCT05069259

Simple Title
A LOW-INTERVENTIONAL, PROSPECTIVE, MULTI-CENTER STUDY TO EVALUATE REAL-WORLD CLINICAL, BIOCHEMICAL AND PATIENT-REPORTED RESPONSES TO TOFACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN SWITZERLAND

Ulcerative Colitis

Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.

Condition

Ulcerative Colitis

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.
Sex
Male or Female
The sex of people who may participate in a clinical trial (all, female, male). Sex is a person’s classification based on assignment at birth. Eligibility based on sex is distinct from eligibility based on gender.
Age
18+ years
The age a person must be to participate in a clinical trial.
View more eligibility criteria on ClinicalTrials.gov

Study Locations

Study Locations
8 trials found.

Clarunis, Universitätsspital

Basel, Switzerland
Recruiting Get directions

Verein IBD Study Group

Bern, Switzerland, CH - 3012
Recruiting Get directions

Inselspital Bern

Bern, Bern (de), Switzerland, 3010
Not yet recruiting Get directions

Kantonsspital St, Gallen

St. Gallen, Sankt Gallen, Switzerland, 9007
Not yet recruiting Get directions

Kantonsspital Baselland

Liestal, Switzerland
Not yet recruiting Get directions

Zentrum für Gastroenterologie und Hepatologie

Zuerich, Switzerland
Not yet recruiting Get directions

University Hospital Zurich

Zurich, Switzerland, 8091
Not yet recruiting Get directions

University Hospital Zurich

Zurich, Switzerland
Not yet recruiting Get directions